HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral tori in chronic hemodialysis patients.

AbstractBACKGROUND:
This study investigated the epidemiology of torus palatinus (TP) and torus mandibularis (TM) in hemodialysis patients and analyzed the influences of hyperparathyroidism on the formation of oral tori.
METHOD:
During 2013, 119 hemodialysis patients were recruited for dental examinations for this study.
RESULTS:
The prevalence of oral tori in our sample group was high at 33.6% (40 of 119). The most common location of tori was TP (70.0%), followed by TM (20.0%), and then both TP and TM (10.0%). Of the 40 tori cases, most (67.5%) were <2 cm in size; moreover, the majority (52.5%) were flat in shape. In symmetry, most (70.0%) occurred in the midline, followed by bilateral sides (20.0%). Notably, the levels of intact parathyroid hormone did not differ in patients with or without tori (P = 0.611). Furthermore, patients with tori did not differ from patients without tori in inflammatory variables such as log high-sensitivity C-reactive protein (P = 1.000) or nutritional variables such as albumin (P = 0.247). Finally, there were no differences between patients with and without tori in adequacy of dialysis (P = 0.577).
CONCLUSIONS:
Neither hyperparathyroidism nor inflammation malnutrition syndrome was found to contribute to the formation of oral tori in chronic hemodialysis patients. Further studies are warranted.
AuthorsPei-Jung Chao, Huang-Yu Yang, Wen-Hung Huang, Cheng-Hao Weng, I-Kuan Wang, Aileen I Tsai, Tzung-Hai Yen
JournalBioMed research international (Biomed Res Int) Vol. 2015 Pg. 897674 ( 2015) ISSN: 2314-6141 [Electronic] United States
PMID25918724 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Aged
  • Exostoses (epidemiology, etiology)
  • Female
  • Humans
  • Hyperparathyroidism (epidemiology, therapy)
  • Male
  • Malnutrition (epidemiology, therapy)
  • Mandible (abnormalities)
  • Middle Aged
  • Palate, Hard (abnormalities)
  • Renal Dialysis (adverse effects)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: